| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |